Mol Cancer Ther (2023) 22 (12_Supplement): PR014.
The Blood Cancer Discovery Award for Outstanding Journal Article is awarded to the corresponding author of a peer-reviewed, original Research Article or Brief published within the previous two years ...
1Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, ...
Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.
1Whitehead Institute for Biomedical Research, Cambridge, Massachusetts. 2Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts. 3Ludwig MIT Center for Molecular ...
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University ...
1Memorial Sloan Kettering Cancer Center, New York, NY. Search for other works by this author on: ...
Abstract 7132: Preclinical characterization of LAE119, a novel PARP1 selective inhibitor and trapper
1Laekna Therapeutics Shanghai Co., Ltd., Shanghai, China.
Search for other works by this author on: ...
1Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. *Corresponding Author: Cari M. Kitahara, Division of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback